Nephrocare Healt

  • Market Cap: Small Cap
  • Industry: Healthcare Services
  • ISIN: INE428V01029
  • NSEID: NEPHROPLUS
  • BSEID: 544647
INR
614.35
-36.1 (-5.55%)
BSENSE

May 20

BSE+NSE Vol: 6.38 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

6.38 lacs (7.96%) Volume

Shareholding (Mar 2026)

FII

9.94%

Held by 20 FIIs

DII

8.64%

Held by 8 DIIs

Promoter

63.85%

Why is Nephrocare Health Services Ltd falling/rising?

20-May-2026

As of 19-May, Nephrocare Health Services Ltd's stock price is at 650.45, reflecting a 1.3% increase. The stock has outperformed the Sensex significantly over various time frames, indicating strong investor confidence and a bullish trend.

As of 19-May, Nephrocare Health Services Ltd's stock price is rising, currently at 650.45, reflecting an increase of 8.35 or 1.3%. This upward movement can be attributed to several factors. Over the past week, the stock has gained 13.37%, significantly outperforming the Sensex, which only increased by 0.86%. Additionally, in the last month, the stock has risen by 11.18%, while the Sensex has declined by 4.19%. Year-to-date, Nephrocare's stock has surged by 38.61%, contrasting sharply with the Sensex's drop of 11.76%.<BR><BR>The stock is also close to its 52-week high, being just 1.81% away from Rs 661.75. On the day of the report, it reached an intraday high of Rs 657, marking a 2.32% increase. Furthermore, Nephrocare is trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a strong bullish trend. <BR><BR>Investor participation has increased, with a delivery volume of 2.6 lacs on 18 May, which is up by 37.97% compared to the 5-day average. This rise in trading activity suggests growing investor confidence in the stock. Overall, these factors contribute to the positive momentum in Nephrocare Health Services Ltd's stock price.

View full answer

Which are the latest news on Nephrocare Healt?

20-May-2026
No latest news for Nephrocare Healt found.

Should I buy, sell or hold Nephrocare Health Services Ltd?

20-May-2026
iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Dashboard

1

The company is Net-Debt Free

 
2

Healthy long term growth as Net Sales has grown by an annual rate of 0% and Operating profit at 0%

 
3

Positive results in Mar 26

4

With ROE of 13.4, it has a Very Expensive valuation with a 10.7 Price to Book Value

5

Increasing Participation by Institutional Investors

stock-summaryMojo Parameters

Mojo Parameters

Loading Valuation Snapshot...

Stock DNA

stock-summary
Industry

Healthcare Services

stock-summary
Market cap

INR 6,169 Cr (Small Cap)

stock-summary
P/E

79.00

stock-summary
Industry P/E

63

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-0.02

stock-summary
Return on Equity

11.74%

stock-summary
Price to Book

11.41

Revenue and Profits:
Net Sales:
266 Cr
(Quarterly Results - Mar 2026)
Net Profit:
30 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
9.9%
0%
9.9%
6 Months
0%
0%
0.0%
1 Year
0%
0%
0.0%
2 Years
0%
0%
0.0%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

Nephrocare Healt for the last several years.

Risk Adjusted Returns v/s stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryNews & Corporate Actions

Announcements stock-summary

Re-Appointment Of Internal Auditor

19-May-2026 | Source : BSE

The Board of Directors at its meeting held on May 19 2026 has re-appointed M/s. BDO India LLP as Internal Auditor as per the disclosure annexed herewith.

Announcement under Regulation 30 (LODR)-Investor Presentation

19-May-2026 | Source : BSE

Please find attached herewith Investor Presentation for quarter and year ended March 31 2026.

Issuance Of Corporate Guarantee

19-May-2026 | Source : BSE

This is to inform you that the Board of Directors in its meeting held on has approved and granted in-principal approval for providing corporate guarantee as per the disclosure annexed herewith.

Corporate Actions stock-summary

stock-summary
BOARD MEETING

No Upcoming Board Meetings

stock-summary
DIVIDEND

No Dividend history available

stock-summary
SPLITS

No Splits history available

stock-summary
BONUS

No Bonus history available

stock-summary
RIGHTS

No Rights history available

stock-summaryKey Factors

Quality key factors stock-summary

Factor
Value
Sales Growth (5y)
0
EBIT Growth (5y)
0
EBIT to Interest (avg)
3.39
Debt to EBITDA (avg)
4.40
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
0.83
Tax Ratio
20.52%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
18.58%
ROCE (avg)
4.47%
ROE (avg)
0

Valuation key factors

Factor
Value
P/E Ratio
79
Industry P/E
63
Price to Book Value
10.74
EV to EBIT
44.95
EV to EBITDA
26.99
EV to Capital Employed
10.89
EV to Sales
6.13
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
24.23%
ROE (Latest)
13.44%

Technicals key factors

Indicator
Weekly
Monthly
MACD
RSI
No Signal
Bollinger Bands
Mildly Bullish
KST
Dow Theory
Bullish
OBV
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Mar 2026stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Promoters

Pledged Promoter Holdings

None

Mutual Funds

Held by 7 Schemes (3.17%)

FIIs

Held by 20 FIIs (9.94%)

Promoter with highest holding

Edoras Investment Holdings Pte Ltd (28.3%)

Highest Public shareholder

Investcorp India Investments Holding Limited (6.29%)

Individual Investors Holdings

5.08%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Mar'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Dec'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "164.33",
          "val2": "160.66",
          "chgp": "2.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "22.08",
          "val2": "22.86",
          "chgp": "-3.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "1.27",
          "val2": "3.96",
          "chgp": "-67.93%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "10.89",
          "val2": "8.45",
          "chgp": "28.88%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "13.44%",
          "val2": "14.23%",
          "chgp": "-0.79%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "alert": "No Half Yearly Results declared by Nephrocare Healt"
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "alert": "No Nine Monthly Results declared by Nephrocare Healt"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'26",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "Not Applicable: The company has declared_date for only one period",
        "dir": 0
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "629.74",
          "val2": "543.60",
          "chgp": "15.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "88.16",
          "val2": "94.89",
          "chgp": "-7.09%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "49.76",
          "val2": "14.30",
          "chgp": "247.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-8.06",
          "val2": "34.24",
          "chgp": "-123.54%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "14.00%",
          "val2": "17.46%",
          "chgp": "-3.46%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Standalone) - Mar'26 - QoQstock-summary

Mar'26
Dec'25
Change(%)
Net Sales
164.33
160.66
2.28%
Operating Profit (PBDIT) excl Other Income
22.08
22.86
-3.41%
Interest
1.27
3.96
-67.93%
Exceptional Items
0.00
0.00
Standalone Net Profit
10.89
8.45
28.88%
Operating Profit Margin (Excl OI)
13.44%
14.23%
-0.79%
Values in Rs Cr.
Direction Arrows
Net Sales

QoQ Growth in quarter ended Mar 2026 is 2.28% vs 3.04% in Dec 2025

Direction Arrows
Standalone Net Profit

QoQ Growth in quarter ended Mar 2026 is 28.88% vs 126.07% in Dec 2025

Annual Results Snapshot (Standalone) - Mar'26stock-summary

Mar'26
Mar'25
Change(%)
Net Sales
629.74
543.60
15.85%
Operating Profit (PBDIT) excl Other Income
88.16
94.89
-7.09%
Interest
49.76
14.30
247.97%
Exceptional Items
0.00
0.00
Standalone Net Profit
-8.06
34.24
-123.54%
Operating Profit Margin (Excl OI)
14.00%
17.46%
-3.46%
Values in Rs Cr.
Net Sales

Not Applicable: The company has declared_date for only one period

Standalone Net Profit

Not Applicable: The company has declared_date for only one period

stock-summaryCompany CV
About Nephrocare Health Services Ltd stock-summary
stock-summary
Nephrocare Health Services Ltd
Small Cap
Healthcare Services
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available